经口机器人手术治疗口咽小唾液腺肿瘤。
Transoral robotic surgery for the management of oropharyngeal minor salivary gland tumors.
机构信息
Department of Otolaryngology-Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York.
出版信息
Head Neck. 2014 Jan;36(1):28-33. doi: 10.1002/hed.23258. Epub 2013 Apr 1.
BACKGROUND
In this study we report our preliminary experience with the use of transoral robotic surgery (TORS) for the management of minor salivary gland malignancies of the oropharynx and outcomes.
METHODS
This was a retrospective review of 10 patients followed over a 5-year period at a single tertiary academic medical center. Patient, tumor, clinicopathologic, functional, and oncologic outcomes were collected and analyzed.
RESULTS
All cancers treated were either T1 (40%) or T2 (60%). Negative margins were achieved in all patients. Four patients received adjuvant radiation therapy (40%). No patients experienced surgical complications and all had excellent functional outcomes. Mean follow-up was 24 months (range, 2-60 months) with locoregional and distant control achieved in 8 patients (80%) and 9 patients (90%), respectively.
CONCLUSIONS
Minor salivary malignancies of the oropharynx are a surgical disease. Short-term follow-up data demonstrate feasibility, low morbidity, good functional, and oncologic results for TORS management of these malignancies.
背景
本研究报告了我们使用经口机器人手术（TORS）治疗口咽部小唾液腺癌的初步经验和结果。
方法
这是一项回顾性研究，对单中心 10 例患者进行了为期 5 年的随访。收集并分析了患者、肿瘤、临床病理、功能和肿瘤学结果。
结果
所有治疗的癌症均为 T1（40%）或 T2（60%）。所有患者均获得阴性切缘。4 例患者接受了辅助放疗（40%）。无手术并发症，所有患者的功能均恢复良好。中位随访时间为 24 个月（范围 2-60 个月），8 例患者（80%）和 9 例患者（90%）达到局部区域和远处控制。
结论
口咽部小唾液腺癌是一种以手术为主的疾病。短期随访数据显示，TORS 治疗这些肿瘤具有可行性、低发病率、良好的功能和肿瘤学结果。
Zotero 插件